MedTrace Logo

The Mechanism of Action of Unite Biomatrix in Venous Leg Ulcers

NCT00953563 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2017-04-05

No results posted yet for this study

Summary

The purpose of this study is to assess the mechanism of action of the Unite Biomatrix and compare its performance with the standard of care, compression therapy alone for the treatment of venous leg ulcers.

Conditions

  • Venous Leg Ulcers

Interventions

DEVICE

Unite Biomatrix

collagen based, decellularized equine pericardial dressing for skin surface wounds

Sponsors & Collaborators

  • Synovis Surgical Innovations

    collaborator INDUSTRY

  • Baxter Healthcare Corporation

    lead INDUSTRY

Principal Investigators

  • Gerit Mulder, DPM · UCSD

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00953563 on ClinicalTrials.gov